Observational Study
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. May 28, 2016; 8(15): 649-658
Published online May 28, 2016. doi: 10.4254/wjh.v8.i15.649
Hepatitis C virus infection in Argentina: Burden of chronic disease
Ezequiel Ridruejo, Fernando Bessone, Jorge R Daruich, Chris Estes, Adrián C Gadano, Homie Razavi, Federico G Villamil, Marcelo O Silva
Ezequiel Ridruejo, Hepatology Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno, Ciudad Autónoma de Buenos Aires C1425ASG, Argentina
Ezequiel Ridruejo, Marcelo O Silva, Hepatology and Liver Transplant Unit, Hospital Universitario Austral, Pilar 1629, Prov. de Buenos Aires, Argentina
Fernando Bessone, Hepatology Section, Escuela de Medicina, Universidad de Rosario, Rosario 2000, Prov. de Santa Fe, Argentina
Jorge R Daruich, Hepatology Section, Hospital de Clínicas San Martín, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires C1120AAF, Argentina
Chris Estes, Homie Razavi, Center for Disease Analysis, Louisville, CO 80026, Unired States
Adrián C Gadano, Hepatology and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires C1181ACH, Argentina
Federico G Villamil, Liver Transplantat Unit, Hospital Británico, Ciudad Autónoma de Buenos Aires C1280AEB, Argentina
Author contributions: Ridruejo E drafted the manuscript; Estes C and Razawi H participated in study design and performed statistical analysis; all authors were involved with data collection, assisted with data analysis, read and approved the final manuscript.
Institutional review board statement: None.
Informed consent statement: None.
Conflict-of-interest statement: Ridruejo E, Bessone F, Daruich JR, Gadano AC, Villamil FG and Silva MO have no conflicts of interest to declare; Estes C and Razavi H and are employees of the Center for Disease Analysis.
Data sharing statement: There is no additional data available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Ezequiel Ridruejo, MD, Hepatology Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno, Avda. Las Heras 2939, Ciudad Autónoma de Buenos Aires C1425ASG, Argentina. eridruejo@gmail.com
Telephone: +54-11-52991221 Fax: +54-11-52990600
Received: January 28, 2016
Peer-review started: January 28, 2016
First decision: February 29, 2016
Revised: April 4, 2016
Accepted: May 10, 2016
Article in press: May 11, 2016
Published online: May 28, 2016
Processing time: 112 Days and 9.1 Hours
Core Tip

Core tip: This is a study evaluating potential policies to diminish hepatitis C virus (HCV) disease burden. Increasing diagnoses and treated individuals with the high current sustained virologic response rates, will diminish HCV disease burden.